Modern development of high-dose-rate brachytherapy.
Itami J.
Jpn J Clin Oncol. 2020 May 5;50(5):490-501. doi: 10.1093/jjco/hyaa029.
Ultra-high dose rate FLASH radiation therapy for cancer.
Kim MM, Zou W.
Med Phys. 2023 Jun;50 Suppl 1(Suppl 1):58-61. doi: 10.1002/mp.16271. Epub 2023 Feb 21.
High dose-rate brachytherapy in the treatment of prostate cancer.
Mendez LC, Morton GC.
Transl Androl Urol. 2018 Jun;7(3):357-370. doi: 10.21037/tau.2017.12.08.
High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.
Strouthos I, Karagiannis E, Zamboglou N, Ferentinos K.
Cancer Rep (Hoboken). 2022 Jan;5(1):e1450. doi: 10.1002/cnr2.1450. Epub 2021 Jun 23.
High Dose Rate Brachytherapy in High-Risk Localised Disease - Why Do Anything Else?
Morton GC, Alrashidi SM.
Clin Oncol (R Coll Radiol). 2020 Mar;32(3):163-169. doi: 10.1016/j.clon.2019.11.003. Epub 2019 Nov 30.
High-dose-rate brachytherapy boost for prostate cancer: rationale and technique.
Morton GC.
J Contemp Brachytherapy. 2014 Oct;6(3):323-30. doi: 10.5114/jcb.2014.45759. Epub 2014 Oct 6.
High-dose-rate brachytherapy as monotherapy for prostate cancer.
Demanes DJ, Ghilezan MI.
Brachytherapy. 2014 Nov-Dec;13(6):529-41. doi: 10.1016/j.brachy.2014.03.002. Epub 2014 Jul 30.
Potential Molecular Mechanisms behind the Ultra-High Dose Rate "FLASH" Effect.
Bogaerts E, Macaeva E, Isebaert S, Haustermans K.
Int J Mol Sci. 2022 Oct 11;23(20):12109. doi: 10.3390/ijms232012109.
Ultra-high dose rate FLASH irradiator at the radiological research accelerator facility.
Garty G, Obaid R, Deoli N, Royba E, Tan Y, Harken AD, Brenner DJ.
Sci Rep. 2022 Dec 22;12(1):22149. doi: 10.1038/s41598-022-19211-7.
Ultra-high dose rate (FLASH) treatment: A novel radiotherapy modality (Review).
Huang J, Cheng J, Shi B, Du X, Tang S, Lin B, Mo J, Yan F, Luo S, Yang H.
Mol Clin Oncol. 2025 Jan 9;22(3):23. doi: 10.3892/mco.2025.2818. eCollection 2025 Mar.
